Artículos de revistas sobre el tema "Diabetes Mellitus, Beta Cells, ACE2, SARS-CoV-2"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 47 mejores artículos de revistas para su investigación sobre el tema "Diabetes Mellitus, Beta Cells, ACE2, SARS-CoV-2".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Nimje, Prajakta D., Vidya Wasnik (Thatere) y Sumeeta Jain. "MANAGEMENT THROUGH AYURVEDIC MEDICATIONS AND LIFESTYLE MODIFICATION (PATHYASEVANA AND YOGASANA) IN A CASE OF POST-COVID COMPLICATION DIABETES MELLITUS (TYPE 2 DM): A SINGLE CASE STUDY". International Ayurvedic Medical Journal 9, n.º 10 (15 de octubre de 2021): 2619–28. http://dx.doi.org/10.46607/iamj5409102021.
Texto completoJunhai, Gazi Rayeeda, Hasi Rani Saha y Bidhan Chandra Sarkar. "Prevalence of COVID-19 Among Older People with Type 2 Diabetes Mellitus: A Systematic Review". International Journal of Science and Healthcare Research 7, n.º 3 (5 de septiembre de 2022): 273–88. http://dx.doi.org/10.52403/ijshr.20220738.
Texto completoKadir, Nursin Abdul y Ida Parwati. "COVID-19 (Symptomatic Non-Respiratory) with Type 2 Diabetes Mellitus". INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY 29, n.º 1 (19 de enero de 2023): 101–6. http://dx.doi.org/10.24293/ijcpml.v29i1.1863.
Texto completoCasillas Santana, Miguel Angel, Juan Antonio Arreguín Cano, Alejandro Dib Kanán, Farid Alonso Dipp Velázquez, Paulina del Carmen Sosa Munguía, Gabriel Alejandro Martínez Castañón, Brenda Eréndida Castillo Silva, Carolina Sámano Valencia y Marco Felipe Salas Orozco. "Should We Be Concerned about the Association of Diabetes Mellitus and Periodontal Disease in the Risk of Infection by SARS-CoV-2? A Systematic Review and Hypothesis". Medicina 57, n.º 5 (13 de mayo de 2021): 493. http://dx.doi.org/10.3390/medicina57050493.
Texto completoBeliard, Kara A., Mabel Yau, Meredith Wilkes, Christopher Joseph Romero, Elizabeth Wallach y Robert Rapaport. "SARS-CoV-2 Infection Related Diabetes Mellitus". Journal of the Endocrine Society 5, Supplement_1 (1 de mayo de 2021): A397. http://dx.doi.org/10.1210/jendso/bvab048.808.
Texto completoPramanik, Parthiba y Purushottam Pramanik. "Diabetes mellitus augments the complications of patients with COVID-19: a review". International Journal of Research in Medical Sciences 8, n.º 7 (26 de junio de 2020): 2716. http://dx.doi.org/10.18203/2320-6012.ijrms20202925.
Texto completoWicik, Zofia, Ceren Eyileten, Daniel Jakubik, Sérgio N. Simões, David C. Martins, Rodrigo Pavão, Jolanta M. Siller-Matula y Marek Postula. "ACE2 Interaction Networks in COVID-19: A Physiological Framework for Prediction of Outcome in Patients with Cardiovascular Risk Factors". Journal of Clinical Medicine 9, n.º 11 (21 de noviembre de 2020): 3743. http://dx.doi.org/10.3390/jcm9113743.
Texto completoPelle, Maria Chiara, Isabella Zaffina, Stefania Lucà, Valentina Forte, Vincenzo Trapanese, Melania Melina, Federica Giofrè y Franco Arturi. "Endothelial Dysfunction in COVID-19: Potential Mechanisms and Possible Therapeutic Options". Life 12, n.º 10 (14 de octubre de 2022): 1605. http://dx.doi.org/10.3390/life12101605.
Texto completoParrey, Ashaq, Abir aijaz, Mohd Ismail, Mir Sadaqat, Murtaza Noor, Yasmeen Amin y Manzoor Koka. "New Onset Diabetes and Its Incidence in Severe COVID 19 Disease A Single Centre Study From Kashmir". Journal of Endocrinology and Diabetes 8, n.º 2 (13 de septiembre de 2012): 1–4. http://dx.doi.org/10.15226/2374-6890/8/2/001152.
Texto completoBlîndu, Emanuel, Renata Gerculy, Diana Opincariu, Daniel Cernica y Imre Benedek. "Cessation of Renin-Angiotensin System Antagonists During the SARS-CoV-2 Pandemic – Do We Have the Evidence?" Journal of Interdisciplinary Medicine 5, n.º 3 (1 de septiembre de 2020): 105–9. http://dx.doi.org/10.2478/jim-2020-0022.
Texto completoIvantsova, N. L., A. G. Beliakova, M. I. Dmitrievskaya, A. N. Useinova, V. M. Melnikova y K. I. Abramova. "PECULIAR PROPERTIES OF USAGE OF DRUGS THAT AFFECT THE RENIN-ANGIOTENSIN SYSTEM IN PATIENTS WITH COVID-19". Crimea Journal of Experimental and Clinical Medicine 11, n.º 2 (2022): 75–81. http://dx.doi.org/10.37279/2224-6444-2021-11-2-75-81.
Texto completoPerlman, Jordan E. y Justin B. Echouffo-Tcheugui. "A Case of Possible SARS-COV-2 Induced Beta-Cell Failure". Journal of the Endocrine Society 5, Supplement_1 (1 de mayo de 2021): A359—A360. http://dx.doi.org/10.1210/jendso/bvab048.732.
Texto completoRivera Nazario, Ivan Augusto, Arnaldo Nieves Ortiz, Jose Ayala Rivera, Kyomara Hernandez Moya, Arnaldo Rojas, Zahira Marie Lugo Lopez, Marina Torres Torres et al. "An Atypical Presentation of Hyperosmolar Hyperglycemic State Induced by SARS CoV 2". Journal of the Endocrine Society 5, Supplement_1 (1 de mayo de 2021): A366—A367. http://dx.doi.org/10.1210/jendso/bvab048.746.
Texto completoZayas, Francisco Jose, Marianne Hernandez-Negron y Michelle Marie Mangual Garcia. "Development of Diabetes Type 3 After SARS-COV-2 Pancreatic B Cell Injury". Journal of the Endocrine Society 5, Supplement_1 (1 de mayo de 2021): A373. http://dx.doi.org/10.1210/jendso/bvab048.760.
Texto completoCavalcante, Letícia Carla de Lima, Larissa Cristina de Lima Cavalcante, Maria Vitória Menezes Coutinho, Rebeca Montenegro De Lacerda, Rodrigo de Oliveira Arakaki y Cristiane Monteiro Da Cruz. "Analysis of the infectional profile of diabetic patients infected by COVID 19 in the period of 2020 – 2021 Análise do perfil de infecção dos pacientes diabéticos infectados pela COVID 19 no período de 2020-2021". Brazilian Journal of Health Review 4, n.º 5 (22 de septiembre de 2021): 19930–40. http://dx.doi.org/10.34119/bjhrv4n5-119.
Texto completoCavalcante, Letícia Carla de Lima, Larissa Cristina de Lima Cavalcante, Maria Vitória Menezes Coutinho, Rebeca Montenegro De Lacerda, Rodrigo de Oliveira Arakaki y Cristiane Monteiro Da Cruz. "Analysis of the infectional profile of diabetic patients infected by COVID 19 in the period of 2020 – 2021 Análise do perfil de infecção dos pacientes diabéticos infectados pela COVID 19 no período de 2020-2021". Brazilian Journal of Health Review 4, n.º 5 (22 de septiembre de 2021): 19930–40. http://dx.doi.org/10.34119/bjhrv4n5-119.
Texto completoKomine, Mayumi, Tuba Mussarat Ansary, Md Razib Hossain, Koji Kamiya y Mamitaro Ohtsuki. "Inflammation Causes Exacerbation of COVID-19: How about Skin Inflammation?" International Journal of Molecular Sciences 23, n.º 20 (14 de octubre de 2022): 12260. http://dx.doi.org/10.3390/ijms232012260.
Texto completoVikulova, O. K., Zamira Zuraeva, L. V. Nikankina y M. V. Shestakova. "The role of renin-angiotensin system and angiotensin-converting enzyme 2 (ACE2) in the development and course of viral infection COVID-19 in patients with diabetes mellitus". Diabetes mellitus 23, n.º 3 (10 de agosto de 2020): 242–49. http://dx.doi.org/10.14341/dm12501.
Texto completoRida, Rima, Paola Rios y Alex Manzano. "A Rare Cause of Diabetes: COVID-19". Journal of the Endocrine Society 5, Supplement_1 (1 de mayo de 2021): A362. http://dx.doi.org/10.1210/jendso/bvab048.737.
Texto completoVinciguerra, Mattia, Silvia Romiti, Khalil Fattouch, Antonio De Bellis y Ernesto Greco. "Atherosclerosis as Pathogenetic Substrate for Sars-Cov2 Cytokine Storm". Journal of Clinical Medicine 9, n.º 7 (3 de julio de 2020): 2095. http://dx.doi.org/10.3390/jcm9072095.
Texto completoKusuma, Victor Perdana y Deasy Ardiany. "The Pathophysiology and Outcomes of Diabetic Patients with Coronavirus Disease 2019 (COVID-19)". Biomolecular and Health Science Journal 4, n.º 2 (30 de octubre de 2021): 124. http://dx.doi.org/10.20473/bhsj.v4i2.30030.
Texto completoSardu, Celestino, Raffaele Marfella, Francesco Prattichizzo, Rosalba La Grotta, Giuseppe Paolisso y Antonio Ceriello. "Effect of Hyperglycemia on COVID-19 Outcomes: Vaccination Efficacy, Disease Severity, and Molecular Mechanisms". Journal of Clinical Medicine 11, n.º 6 (12 de marzo de 2022): 1564. http://dx.doi.org/10.3390/jcm11061564.
Texto completoKhaydarova, F. A., N. U. Alimova, A. V. Alieva, A. S. Sadykova y M. D. Aripova. "Impact of COVID-19 infection on the development of type 1 diabetes mellitus in children and adolescents". Diabetes mellitus 25, n.º 1 (22 de marzo de 2022): 21–26. http://dx.doi.org/10.14341/dm12785.
Texto completoMcCord, Joe M., Brooks M. Hybertson, Adela Cota-Gomez, Kara P. Geraci y Bifeng Gao. "Nrf2 Activator PB125® as a Potential Therapeutic Agent against COVID-19". Antioxidants 9, n.º 6 (12 de junio de 2020): 518. http://dx.doi.org/10.3390/antiox9060518.
Texto completoJC, Ekezie y Haddad D. "New Onset Type-1 Diabetes Mellitus in a Toddler with Sars-Cov-2 Infection Presenting In Diabetic Ketoacidosis: A Case Report". New Medical Innovations and Research 2, n.º 5 (21 de octubre de 2021): 01–03. http://dx.doi.org/10.31579/2767-7370/022.
Texto completoEvi Awwaliyah, Hotimah y Michio Shimabukuro. "Clinical characteristics and mortality associated with COVID-19 in islamic hospital of Jemursari, Surabaya, Indonesia: A hospital-based retrospective cohort study". Bali Medical Journal 11, n.º 3 (15 de septiembre de 2022): 1202–6. http://dx.doi.org/10.15562/bmj.v11i3.3541.
Texto completoBabenko, A. Yu y M. Yu Laevskaya. "Diabetes mellitus and COVID-19. How are they connected? Current strategy of fight". "Arterial’naya Gipertenziya" ("Arterial Hypertension") 26, n.º 3 (25 de junio de 2020): 304–11. http://dx.doi.org/10.18705/1607-419x-2020-26-3-304-311.
Texto completoKara, Mehmet y Ilhami Celik. "Effect of clinical progress in antihypertensive medications among COVID-19 patients". Medical Science and Discovery 9, n.º 10 (24 de octubre de 2022): 593–98. http://dx.doi.org/10.36472/msd.v9i10.829.
Texto completoMartinez, Alfonso Hoyos, Kelly Anne Hicks, Tracy Patel Moorjani, Jennifer Bell y Yuezhen Lin. "A Case of Autoantibody Negative Pediatric Diabetes Mellitus With Marked Insulin Resistance Concomitant With COVID-19: A Novel Form of Disease?" Journal of the Endocrine Society 5, Supplement_1 (1 de mayo de 2021): A690—A691. http://dx.doi.org/10.1210/jendso/bvab048.1406.
Texto completoAlqaisi, Sura y Ali Rahman. "ODP649 COVID-19 Induced Diabetic Ketoacidosis Which Unmasked Latent Autoimmune Diabetes In Adult". Journal of the Endocrine Society 6, Supplement_1 (1 de noviembre de 2022): A346—A347. http://dx.doi.org/10.1210/jendso/bvac150.721.
Texto completoWasilewska, Inga, Jakub Rezmer y Łukasz Świątek. "Diabetes mellitus and COVID-19: current state of knowledge". Journal of Education, Health and Sport 12, n.º 8 (25 de agosto de 2022): 1170–75. http://dx.doi.org/10.12775/jehs.2022.12.08.101.
Texto completoYatskov, I. A., V. A. Beloglazov y E. I. Ryapova. "Lipopolysaccharide and ARDS caused by new coronavirus infection: hypotheses and facts". Medical Immunology (Russia) 24, n.º 1 (10 de marzo de 2022): 7–18. http://dx.doi.org/10.15789/1563-0625-laa-2229.
Texto completoSchiaffini, Riccardo, Andrea Campana, Annalisa Deodati, Emanuela Peschiaroli, Maria Francesca Lanzillotta y Alessandra Fierabracci. "SARS-CoV-2 infection as possible downstream disease precipitator in autoantibody-positive insulin-dependent diabetes mellitus: a case report". Italian Journal of Pediatrics 48, n.º 1 (23 de febrero de 2022). http://dx.doi.org/10.1186/s13052-022-01226-5.
Texto completoAkkuş, Gamze. "Newly-onset Autoimmune Diabetes Mellitus triggered by Covid 19 infection: A case based review". Endocrine, Metabolic & Immune Disorders - Drug Targets 22 (4 de octubre de 2022). http://dx.doi.org/10.2174/2666145415666221004111511.
Texto completoSteenblock, Charlotte, Stefanie Richter, Ilona Berger, Marko Barovic, Janine Schmid, Undine Schubert, Natalia Jarzebska et al. "Viral infiltration of pancreatic islets in patients with COVID-19". Nature Communications 12, n.º 1 (10 de junio de 2021). http://dx.doi.org/10.1038/s41467-021-23886-3.
Texto completoLazartigues, Eric, Mirza Muhammad Fahd Qadir y Franck Mauvais-Jarvis. "Endocrine Significance of SARS-CoV-2’s Reliance on ACE2". Endocrinology 161, n.º 9 (11 de julio de 2020). http://dx.doi.org/10.1210/endocr/bqaa108.
Texto completoShao, Shiying, Qin Yang, Ruping Pan, Xuefeng Yu y Yong Chen. "Interaction of Severe Acute Respiratory Syndrome Coronavirus 2 and Diabetes". Frontiers in Endocrinology 12 (6 de octubre de 2021). http://dx.doi.org/10.3389/fendo.2021.731974.
Texto completoAl-kuraishy, Hayder M., Ali I. Al-Gareeb, M. Alblihed, Susana G. Guerreiro, Natália Cruz-Martins y Gaber El-Saber Batiha. "COVID-19 in Relation to Hyperglycemia and Diabetes Mellitus". Frontiers in Cardiovascular Medicine 8 (20 de mayo de 2021). http://dx.doi.org/10.3389/fcvm.2021.644095.
Texto completo"COVID-19 y su asociación con los inhibidores de la enzima convertidora de angiotensina y los antagonistas de los receptores para angiotensina II". Revista de la Facultad de Medicina 63, n.º 4 (10 de julio de 2020): 30–34. http://dx.doi.org/10.22201/fm.24484865e.2020.63.4.05.
Texto completoNouri-Keshtkar, Marjan, Sara Taghizadeh, Aisan Farhadi, Aysan Ezaddoustdar, Samira Vesali, Roya Hosseini, Mehdi Totonchi et al. "Potential Impact of Diabetes and Obesity on Alveolar Type 2 (AT2)-Lipofibroblast (LIF) Interactions After COVID-19 Infection". Frontiers in Cell and Developmental Biology 9 (8 de julio de 2021). http://dx.doi.org/10.3389/fcell.2021.676150.
Texto completoOkoduwa, Stanley I. R., Daniel H. Mhya, Idongesit A. Enang y Akinbobola O. Salawu. "Diabetes Mellitus and COVID-19: Possible Interactions and Mechanisms in Comorbid Patients". Journal of Health Science and Medical Research, 27 de octubre de 2022. http://dx.doi.org/10.31584/jhsmr.2022904.
Texto completoNajafi, Reza, Nahid Mamizadeh, Seyed Hossein Hosseini, Sima Roushenas y Leila Bazhdan. "A challenging case of COVID-19: a COVID-19 positive adolescent presented with severe diabetic ketoacidosis, resistant hypertension". BMC Endocrine Disorders 22, n.º 1 (5 de abril de 2022). http://dx.doi.org/10.1186/s12902-022-00979-8.
Texto completoAlizadeh, Shaban, Reza Afrisham, Yasaman Jadidi, Maryam Davoudi, Kiana Moayedi, Omid Soleimanifar, Chrysovalantou Eleni Xirouchaki, Damoon Ashtary-larky y Shadisadat Seyyedebrahimi. "Gastrointestinal, liver, pancreas, oral and psychological long-term symptoms of COVID-19 after recovery; A review". Mini-Reviews in Medicinal Chemistry 23 (16 de noviembre de 2022). http://dx.doi.org/10.2174/1389557523666221116154907.
Texto completoSchipani, Elena, Andrea Cozzi, Giuseppe Salvatore Murgida, Valentina Francolini, Eleonora Sisti, Stefania Di Martino, Francesca Dainelli, Rosa Vecchio, Elisa Grifoni y Luca Masotti. "New-onset type 1 diabetes mellitus triggered by SARS-CoV-2 infection in a patient with Hashimoto thyroiditis: a case report". Italian Journal of Medicine, 25 de enero de 2021. http://dx.doi.org/10.4081/itjm.2021.1387.
Texto completoRoeroe, Pomantow A. L., Bisuk P. Sedli y Octavianus Umboh. "Faktor Risiko Terjadinya Coronavirus Disease 2019 (Covid-19) pada Penyandang Diabetes Melitus Tipe 2". e-CliniC 9, n.º 1 (4 de enero de 2021). http://dx.doi.org/10.35790/ecl.v9i1.32301.
Texto completoPatel, Sanyamee, Prashilkumar Patel, Ayushi Mehta, Ishan Patel, Shubham Thakor y Om Lumbhani. "incidence of myocarditis and pericarditis in post COVID-19 unvaccinated patients". International journal of health sciences, 31 de julio de 2022, 11743–51. http://dx.doi.org/10.53730/ijhs.v6ns5.11049.
Texto completoSaheb Sharif-Askari, Fatemeh, Narjes Saheb Sharif-Askari, Shirin Hafezi, Swati Goel, Hawra Ali Hussain Alsayed, Abdul Wahid Ansari, Bassam Mahboub et al. "Upregulation of interleukin-19 in saliva of patients with COVID-19". Scientific Reports 12, n.º 1 (26 de septiembre de 2022). http://dx.doi.org/10.1038/s41598-022-20087-w.
Texto completo